These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 31213788

  • 1. Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting.
    Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK.
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1063-1073. PubMed ID: 31213788
    [Abstract] [Full Text] [Related]

  • 2. Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
    Mathioudakis AG, Bikov A, Foden P, Lahousse L, Brusselle G, Singh D, Vestbo J.
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32108044
    [Abstract] [Full Text] [Related]

  • 3. Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.
    Siddiqui SH, Pavord ID, Barnes NC, Guasconi A, Lettis S, Pascoe S, Petruzzelli S.
    Int J Chron Obstruct Pulmon Dis; 2018 May; 13():3669-3676. PubMed ID: 30464449
    [Abstract] [Full Text] [Related]

  • 4. Association between COPD exacerbations and lung function decline during maintenance therapy.
    Kerkhof M, Voorham J, Dorinsky P, Cabrera C, Darken P, Kocks JW, Sadatsafavi M, Sin DD, Carter V, Price DB.
    Thorax; 2020 Sep; 75(9):744-753. PubMed ID: 32532852
    [Abstract] [Full Text] [Related]

  • 5. Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review.
    Whittaker HR, Jarvis D, Sheikh MR, Kiddle SJ, Quint JK.
    Respir Res; 2019 Dec 04; 20(1):277. PubMed ID: 31801539
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2016 Dec 04; 11():2341-2348. PubMed ID: 27703344
    [Abstract] [Full Text] [Related]

  • 7. Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD.
    Cheng SL, Wang HH, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2017 Dec 04; 12():2231-2238. PubMed ID: 28814851
    [Abstract] [Full Text] [Related]

  • 8. Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients.
    Park HY, Lee H, Koh WJ, Kim S, Jeong I, Koo HK, Kim TH, Kim JW, Kim WJ, Oh YM, Sin DD, Lim SY, Lee SD, KOLD Study Group.
    Int J Chron Obstruct Pulmon Dis; 2016 Dec 04; 11():23-30. PubMed ID: 26730185
    [Abstract] [Full Text] [Related]

  • 9. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH, Lee CH, Kim JW, Lee WY, Jung JY, Park JH, Jung KS, Yoo KH, Park YB, Kim DK.
    Int J Chron Obstruct Pulmon Dis; 2017 Dec 04; 12():2455-2464. PubMed ID: 28860740
    [Abstract] [Full Text] [Related]

  • 10. ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils.
    Low EV, Hughes SM, Zaffarullah S, Kantas D, Stockley RA, Turner AM.
    Respiration; 2018 Dec 04; 95(2):114-121. PubMed ID: 29253843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA, Franssen FME, van Kraaij S, Braeken DCW, Wouters EFM, Maitland-van der Zee AH, Driessen JHM, de Vries F.
    COPD; 2019 Apr 04; 16(2):152-159. PubMed ID: 31117850
    [Abstract] [Full Text] [Related]

  • 13. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD.
    Barnes NC, Sharma R, Lettis S, Calverley PM.
    Eur Respir J; 2016 May 04; 47(5):1374-82. PubMed ID: 26917606
    [Abstract] [Full Text] [Related]

  • 14. Withdrawal of Inhaled Corticosteroids from Patients with COPD; Effect on Exacerbation Frequency and Lung Function: A Systematic Review.
    Georgiou A, Ramesh R, Schofield P, White P, Harries TH.
    Int J Chron Obstruct Pulmon Dis; 2024 May 04; 19():1403-1419. PubMed ID: 38919905
    [Abstract] [Full Text] [Related]

  • 15. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population.
    Vestbo J, Vogelmeier CF, Small M, Siddall J, Fogel R, Kostikas K.
    Int J Chron Obstruct Pulmon Dis; 2019 May 04; 14():853-861. PubMed ID: 31114183
    [Abstract] [Full Text] [Related]

  • 16. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH, Kim YS, Linton JA, Nam CM, Choi Y, Park EC.
    Respir Med; 2017 Sep 04; 130():75-84. PubMed ID: 29206637
    [Abstract] [Full Text] [Related]

  • 17. Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in Chronic Obstructive Pulmonary Disease? Results from Post Hoc Subgroup Analyses.
    Iqbal A, Barnes NC, Brooks J.
    Clin Drug Investig; 2015 Oct 04; 35(10):685-8. PubMed ID: 26329916
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD.
    Hartjes FJ, Vonk JM, Faiz A, Hiemstra PS, Lapperre TS, Kerstjens HAM, Postma DS, van den Berge M, Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group.
    Respirology; 2018 Nov 04; 23(11):1023-1031. PubMed ID: 29696728
    [Abstract] [Full Text] [Related]

  • 19. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
    Pignatti P, Visca D, Zappa M, Zampogna E, Saderi L, Sotgiu G, Centis R, Migliori GB, Spanevello A.
    BMC Pulm Med; 2024 May 19; 24(1):247. PubMed ID: 38764008
    [Abstract] [Full Text] [Related]

  • 20. COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
    Savran O, Godtfredsen N, Sørensen T, Jensen C, Ulrik CS.
    Respir Res; 2021 Feb 12; 22(1):54. PubMed ID: 33579297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.